https://www.selleckchem.com/pr....oducts/5-chloro-2-de
Although updates to current PGD treatment are lacking, future therapies are promising with targeted therapy and the use of EVLP to pharmacologically recondition donor lungs. There is significant progress in defining PGD and identifying its several risk factors, but effective prevention and treatment strategies are needed. There is significant progress in defining PGD and identifying its several risk factors, but effective prevention and treatment strategies are needed. Chronic lung allograft dysfunction (CLAD) limits the
Like
Comment
Share
